Myeloablative transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Antilymphocyte Serum Hematopoietic Stem Cells Bone Marrow T-Lymphocytes Bone Marrow Cells Fetal Blood Transplants Granulocyte-Macrophage Progenitor Cells Liver Portal Vein Stem Cells Neutrophils Cells, Cultured Kidney Hepatic Artery Allografts Hepatic Veins Amnion Mesenchymal Stromal Cells

Organisms8

Transplantation Chimera Mice, Inbred C57BL Rats, Inbred Lew Mice, Inbred BALB C Chimera Radiation Chimera Cytomegalovirus Mice, SCID

Diseases55

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia Hepatic Veno-Occlusive Disease Lymphoma, Non-Hodgkin Multiple Myeloma Myelodysplastic Syndromes Leukemia, Myeloid, Acute Liver Failure Acute Disease Neuroblastoma Postoperative Complications Mucositis Infection Hematologic Diseases Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, Follicular Cadaver Lymphoma Bone Marrow Diseases Cytomegalovirus Infections Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Liver Diseases Hodgkin Disease Opportunistic Infections Neoplasm, Residual Kidney Failure, Chronic Bronchiolitis Obliterans Neoplasm Recurrence, Local Anemia, Aplastic Blood Group Incompatibility End Stage Liver Disease Sarcoma, Ewing Brain Death Chronic Disease Lymphoma, Mantle-Cell Liver Failure, Acute Disease Progression Primary Graft Dysfunction Liver Cirrhosis Delayed Graft Function Biliary Atresia Neoplasms Liver Neoplasms Disease Models, Animal Lymphoproliferative Disorders Carcinoma, Hepatocellular Reperfusion Injury Severe Combined Immunodeficiency Kidney Diseases Death Diabetes Mellitus, Type 1 Biliary Tract Diseases

Chemicals and Drugs43

Myeloablative Agonists Busulfan Immunosuppressive Agents Melphalan Vidarabine Cyclophosphamide Thiotepa Antilymphocyte Serum Cyclosporine Antigens, CD34 Etoposide HLA Antigens Granulocyte Colony-Stimulating Factor Yttrium Radioisotopes Vincristine Tacrolimus Carmustine Cytarabine Idarubicin Antibodies, Monoclonal Methylprednisolone Antineoplastic Agents, Alkylating Propantheline Doxorubicin Antineoplastic Agents Antibodies, Neoplasm Prednisone Antigens, CD20 Mycophenolic Acid ABO Blood-Group System Carboplatin Antigens, CD 3-Iodobenzylguanidine Methotrexate Isoantibodies Dexamethasone Azathioprine Organ Preservation Solutions Cyclosporins Recombinant Proteins Iodine Radioisotopes Biological Markers Isoantigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Transplantation, Homologous Hematopoietic Stem Cell Transplantation Transplantation Conditioning Liver Transplantation Bone Marrow Transplantation Transplantation, Autologous Kidney Transplantation Cord Blood Stem Cell Transplantation Stem Cell Transplantation Whole-Body Irradiation Heart Transplantation Lung Transplantation Treatment Outcome Organ Transplantation Histocompatibility Testing Peripheral Blood Stem Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Combined Modality Therapy Transplantation Retrospective Studies Transplantation, Isogeneic Cell Transplantation Survival Analysis Remission Induction Survival Rate Bone Marrow Purging Disease-Free Survival Transplantation, Heterotopic Heart-Lung Transplantation Antineoplastic Combined Chemotherapy Protocols Radioimmunotherapy Hematopoietic Stem Cell Mobilization Follow-Up Studies Lymphocyte Depletion Immunosuppression Fetal Tissue Transplantation Skin Transplantation Leukapheresis Blood Component Removal Transplantation, Heterologous Mesenchymal Stem Cell Transplantation Risk Factors Corneal Transplantation Prognosis Tissue Transplantation Salvage Therapy Prospective Studies Brain Tissue Transplantation Facial Transplantation Donor Selection Incidence Platelet Count Organ Preservation Leukocyte Count Kaplan-Meier Estimate Platelet Transfusion Life Tables Multivariate Analysis Hand Transplantation Postoperative Period Pilot Projects Tissue and Organ Harvesting Feasibility Studies Lymphocyte Count Blood Cell Count Cell Count Colony-Forming Units Assay Flow Cytometry Cohort Studies Cell Separation Neoplasm Transplantation Patient Selection Radiometry Radiotherapy Dosage Proportional Hazards Models Biopsy Lymphocyte Transfusion Actuarial Analysis Polymerase Chain Reaction Cold Ischemia Anastomosis, Surgical Fatal Outcome Risk Hepatectomy Disease Models, Animal Cause of Death Models, Animal Postoperative Care Heart-Assist Devices Reoperation Graft Enhancement, Immunologic Risk Assessment Cryopreservation Leukocyte Transfusion Warm Ischemia Tissue Preservation Blood Grouping and Crossmatching Liver Function Tests Preoperative Care Dose-Response Relationship, Radiation Immunohistochemistry

Psychiatry and Psychology1

Phenomena and Processes24

Graft Survival Graft Rejection Transplantation Immunology Histocompatibility Time Factors Transplantation Tolerance Chimerism Hematopoiesis Graft vs Tumor Effect Graft vs Leukemia Effect Platelet Count Leukocyte Count Lymphocyte Count Blood Cell Count Cell Count Cell Differentiation Risk Graft vs Host Reaction Immune Tolerance Immunocompromised Host Radiation Chimera Dose-Response Relationship, Drug Regeneration Dose-Response Relationship, Radiation

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science5

Survival Rate Incidence Life Tables Fatal Outcome Cause of Death

Named Groups5

Tissue Donors Unrelated Donors Living Donors Siblings Infant, Newborn

Health Care31

Treatment Outcome Retrospective Studies Survival Analysis Survival Rate Disease-Free Survival Tissue and Organ Procurement Follow-Up Studies Waiting Lists Risk Factors Prospective Studies Donor Selection Incidence Kaplan-Meier Estimate Life Tables Multivariate Analysis Postoperative Period Pilot Projects Feasibility Studies Cohort Studies Patient Selection Proportional Hazards Models Age Factors Actuarial Analysis Fatal Outcome Risk Cause of Death Postoperative Care Risk Assessment Preoperative Care Dose-Response Relationship, Radiation Directed Tissue Donation

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Myeloablative Agonists Transplantation, Homologous Hematopoietic Stem Cell Transplantation Transplantation Conditioning Liver Transplantation Bone Marrow Transplantation Transplantation, Autologous Kidney Transplantation Graft vs Host Disease Cord Blood Stem Cell Transplantation Stem Cell Transplantation Whole-Body Irradiation Heart Transplantation Graft Survival Lung Transplantation Hematologic Neoplasms Busulfan Transplantation Chimera Tissue Donors Treatment Outcome Organ Transplantation Histocompatibility Testing Peripheral Blood Stem Cell Transplantation Graft Rejection Immunosuppressive Agents Pancreas Transplantation Islets of Langerhans Transplantation Combined Modality Therapy Transplantation Retrospective Studies Transplantation Immunology Melphalan Recurrence Transplantation, Isogeneic Cell Transplantation Vidarabine Survival Analysis Unrelated Donors Remission Induction Living Donors Histocompatibility Cyclophosphamide Thiotepa Survival Rate Bone Marrow Purging Time Factors Disease-Free Survival Leukemia Hepatic Veno-Occlusive Disease Transplantation, Heterotopic Heart-Lung Transplantation Antilymphocyte Serum Siblings Antineoplastic Combined Chemotherapy Protocols Lymphoma, Non-Hodgkin Radioimmunotherapy Multiple Myeloma Hematopoietic Stem Cell Mobilization Myelodysplastic Syndromes Tissue and Organ Procurement Hematopoietic Stem Cells Transplantation Tolerance Follow-Up Studies Cyclosporine Antigens, CD34 Etoposide Leukemia, Myeloid, Acute Liver Failure Lymphocyte Depletion Immunosuppression HLA Antigens Granulocyte Colony-Stimulating Factor Fetal Tissue Transplantation Acute Disease Neuroblastoma Skin Transplantation Postoperative Complications Mucositis Leukapheresis Chimerism Hematopoiesis Waiting Lists Blood Component Removal Transplantation, Heterologous Infection Mesenchymal Stem Cell Transplantation Risk Factors Corneal Transplantation Prognosis Graft vs Tumor Effect Yttrium Radioisotopes Bone Marrow Vincristine Hematologic Diseases Precursor Cell Lymphoblastic Leukemia-Lymphoma Tacrolimus Tissue Transplantation Salvage Therapy Carmustine Lymphoma, Follicular

No FAQ available that match "myeloablative transplantation"